QQ客服 官方微博 反馈留言

	TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing.
	Zheng, Huili; Wang, Yan*; Tang, Chuanning; Jones, Lindsey; Ye, Hua; Zhang, Guangchun; Cao, Weihai; Li, Jingwen; Liu, Lifeng; Liu, Zhencong
刊名	Cancer Genomics and Proteomics
	2016
卷号	13期号:3页码:231-238
关键词	Esophageal cancer Genetic mutations Ion PGM Next-generation sequencing Personalized medicine Targeted therapy
ISSN号	1109-6535
URL标识	查看原文
WOS记录号	WOS:000375329300006;PMID:27107065
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5676301
专题	南华大学
作者单位	1.[Wang, Yan 2.Cao, Weihai 3.Zheng, Huili 4.Liu, Lifeng 5.Li, Jingwen 6.Liu, Zhencong 7.Zhang, Chao] First Hosp Qiqihar, Qiqihar 161005, Peoples R China.
推荐引用方式 GB/T 7714	Zheng, Huili,Wang, Yan*,Tang, Chuanning,et al. TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing.[J]. Cancer Genomics and Proteomics,2016,13(3):231-238.
APA	Zheng, Huili.,Wang, Yan*.,Tang, Chuanning.,Jones, Lindsey.,Ye, Hua.,...&Chen, Si-Yi*.(2016).TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing..Cancer Genomics and Proteomics,13(3),231-238.
MLA	Zheng, Huili,et al."TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing.".Cancer Genomics and Proteomics 13.3(2016):231-238.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。